Proximagen Limited
Records under this name other than the patents Proximagen Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,369,616 | Drug Combination and Its Use in Therapy Formerly held Lapsed on the fee record Ended Jun 28, 2026 · High confidence | Lapsed on the fee record | Ended Jun 28, 2026 | High confidence |
| US 11,311,552 | Therapies for cancer Lapsed on the fee record Ended Apr 26, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 26, 2026 | From the USPTO record |
| US 9,951,068 | Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors Lapsed on the fee record Ended Apr 24, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2026 | From the USPTO record |
| US 9,890,160 | Compounds I Lapsed on the fee record Ended Feb 13, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 13, 2026 | From the USPTO record |
| US 8,569,338 | Methods of using 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine compounds Lapsed on the fee record Ended Oct 29, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 29, 2025 | From the USPTO record |
| US 11,040,969 | Compounds I Lapsed on the fee record Ended Jun 22, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 22, 2025 | From the USPTO record |
| US 9,676,769 | Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors Lapsed on the fee record Ended Jun 13, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 13, 2025 | From the USPTO record |
| US 10,995,091 | CXCR4 receptor antagonists Lapsed on the fee record Ended May 4, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 4, 2025 | From the USPTO record |
| US 10,968,223 | Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors Lapsed on the fee record Ended Apr 6, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 6, 2025 | From the USPTO record |
| US 9,580,415 | Compounds Lapsed on the fee record Ended Feb 28, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 28, 2025 | From the USPTO record |